Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers
- PMID: 957503
- DOI: 10.1016/s0022-5347(17)58808-4
Contribution to therapeutic decisions of ratios, absolute values and other measures of calcium, magnesium, urate or oxalate balance in stone formers
Abstract
Investigation of multiple serum and urinary factors in 44 patients with calcium urinary stone disease confirmed a number of defects that have been described previously: elevation of mean serum calcium and uric acid above normal, and depression of mean serum magnesium. Urinary excretion of calcium and uric acid was increased and was increased and was probably related to food ingestion. Urinary magnesium also increased after eating but less than calcium, with the result that for most patients the magnesium to calcium x 100 ratio approached levels observed in stone formation. Urinary oxalate excretion was constant during the entire observation period and apparently was not affected by ingestion of a defined diet. Nine additional patients had persistent hypercalcemia owing to hyperparathyroidism (5 confirmed, 1 suspected), malignancy (2) and drug ingestion (1). Metabolic evaluation of patients with calcium urinary calculi continues to contribute to decisions regarding their best therapeutic regimen.
Similar articles
-
[Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].Hinyokika Kiyo. 1987 Sep;33(9):1321-30. Hinyokika Kiyo. 1987. PMID: 3434487 Japanese.
-
The evaluation of some biochemical parameters in pyridoxine-treated calcium oxalate renal stone formers.Urol Int. 1977;32(4):348-52. doi: 10.1159/000280150. Urol Int. 1977. PMID: 929778
-
Quantitative element investigations in urine, serum, kidney and muscle tissue of calcium oxalate stone patients.Eur Urol. 1978;4(3):206-11. doi: 10.1159/000473951. Eur Urol. 1978. PMID: 658076
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
-
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.Scand J Urol Nephrol Suppl. 1989;119:1-53. Scand J Urol Nephrol Suppl. 1989. PMID: 2669121 Review.
Cited by
-
Risk formulas in calcium oxalate urolithiasis.World J Urol. 1997;15(3):176-85. doi: 10.1007/BF02201855. World J Urol. 1997. PMID: 9228725 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources